Drug Shortage Report for TEVA-TEMOZOLOMIDE
Report ID | 218986 |
Drug Identification Number | 02441160 |
Brand name | TEVA-TEMOZOLOMIDE |
Common or Proper name | TEMOZOLOMIDE 5MG CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TEMOZOLOMIDE |
Strength(s) | 5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 5 |
ATC code | L01AX |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-07 |
Estimated end date | 2024-09-20 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-02-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-02-08 | French | Compare |
v1 | 2024-02-08 | English | Compare |
Showing 1 to 2 of 2